Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase (Q34165621)

31 July 2017

title

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase (English)

1 reference

31 July 2017

1 reference

William B Parker

1 reference

31 July 2017

Paula W Allan

1 reference

31 July 2017

Abdalla E A Hassan

1 reference

31 July 2017

John A Secrist

1 reference

31 July 2017

Eric J Sorscher

1 reference

31 July 2017

William R Waud

1 reference

31 July 2017

publication date

1 January 2003

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

23-29

1 reference

In VivoGene Therapy of Cancer withE. coliPurine Nucleoside Phosphorylase

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Foamy virus vectors for suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Converting cancer genes into killer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

A convenient synthesis of 2'-deoxy-2-fluoroadenosine; a potential prodrug for suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

Cell to Cell Contact Is Not Required for Bystander Cell Killing by Escherichia coli Purine Nucleoside Phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

inferred from DOI database lookup

7 January 2021

based on heuristic

Analogs of 6-methyl-9.beta.-D-ribofuranosylpurine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700520

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700520

1 reference

31 July 2017

1 reference